Abstract
Lipid droplets (LDs) are dynamic storage organelles that are involved in lipid homeostasis. Hepatitis C virus (HCV) is closely associated with LDs. HCV Core and nonstructural (NS) proteins colocalize with LDs, and presumably are involved in virion formation at that site. We demonstrated that HCV NS4B, an integral membrane protein in endoplasmic reticulum, strongly targeted LDs. Confocal imaging studies showed that NS4B localized at the margins of LDs. Biochemical fractionation of HCV-replicating cells suggested that NS4B existed in membranes associated with LDs rather than on the LD surface membrane itself. The N-and C-terminal cytosolic domains of NS4B showed targeting of LDs, with the former being much stronger. In both domains, activity was present in the region containing an amphipathic -helix in which 10 hydrophobic residues were identified as putative determinants for targeting LDs. JFH1 mutants with alanine substitutions for the hydrophobic residues were defective for virus replication.
W43A mutant with a single alanine substitution showed loss of association of NS4B with LDs and severely reduced release of infectious virions compared with wild-type JFH1. NS4B plays a crucial role in virus replication at the site of virion formation, namely, the microenvironment associated with LDs.
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by guest, on www.jlr.org Downloaded from such as Core (15) and NS proteins [NS2 (16) , NS3, NS4A, NS4B, NS5A (17) , and NS5B] and HCV RNAs, also localize at sites close to LDs (4) . Core and NS5A are thought to mediate association of these HCV components with LDs (4); however, the molecular mechanisms by which NS proteins associate with LDs remain unclear.
Ultrastructural studies showed accumulation of virion-like structures around LDs (18) .
Although several cellular and viral proteins localize on the LD membrane, consensus signals for LD targeting are not defined (1) . Recent reports have shown that LD-targeting activity resides in amphipathic helices (19) (20) (21) (22) (23) or in hydrophobic regions (24) (25) (26) .
Here, we present evidence that HCV NS4B strongly targets LDs. NS4B is a 261-amino-acid, multifunctional protein consisting of N-and C-terminal cytosolic domains and a central membrane domain harboring at least four transmembrane helices (27) . NS4B is an integral membrane protein in ER (28) that can induce alteration of the membrane structure to form a membranous web (29) , in which HCV RNA replication is thought to occur (30) (31) (32) . We provide evidence to suggest how ER-resident protein NS4B can interact with LDs. Imaging studies including a series of mutation analyses revealed the regions responsible for LD targeting of NS4B. The hydrophobic amino acid residues in amphipathic -helices are critical for LD targeting. The JFH1 (33) mutant harboring alanine substitutions for the hydrophobic residues of NS4B was defective for virus replication. In a single alanine substitution mutant, W43A, we observed that loss of LD targeting of NS4B caused a severe defect in virus replication.
Our results strongly suggest that NS4B functions at sites close to LDs, which is critical for replication of HCV.
MATERIALS AND METHODS

Cell culture system
Oc cells (34) and OR6 HCV-RNA-replicating cells (35) were cultured in collagen (type I)-coated dishes (Iwaki, Chiba, Japan) with DMEM (Sigma) supplemented with 10% FBS, penicillin, and streptomycin.
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Antibodies
The antibodies used in this study were those against Core (CP11; MBL, Nagoya, Japan), NS3 (R212), NS4B (52-1, detection for HCV-O NS4B), NS4AB (RR12, detection for JFH1 NS4B), NS5A (8926; BioAcademia, Osaka, Japan), NS5B (NS5B-6, BioAcademia), adipose differentiation-related protein (ADRP; Abcam), FLAG ® (Sigma), myc-tag (MBL), mCherry (Clontech), glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Millipore), and calnexin (BD Transduction Laboratories). The anti-NS3 (R212), anti-NS4B (52-1), and anti-NS4AB (RR12) antibodies were gifts from Dr. M. Kohara (Tokyo Metropolitan Institute of Medical Science, Japan). Rabbit polyclonal antibodies specific to JFH1 NS3, NS5A, and NS5B were raised against bacterially expressed GST-NS3 (amino acids 165-631), -NS5A (amino acids 25-466),
and -NS5B (amino acids 1-570), respectively. Alexa-Fluor-555-conjugated anti-rabbit IgG (Invitrogen), Alexa-Fluor-568-conjugated anti-mouse IgG (Invitrogen), and rhodamine-conjugated anti-mouse IgG (Cappel) antibodies were also used. Proteins were resolved on 8 or 12% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (GE Healthcare). The membranes were rinsed in water and then soaked in TBS-0.1% Tween 20 (TBST) for 30 min to enhance detection sensitivity (37) . The membranes were again rinsed in water and blocked with PVDF Blocking Reagent (Toyobo, Osaka, Japan) for 1 h at room temperature. The membranes were reacted with an appropriate dilution of primary antibody in Can Get
Expression plasmids
Signal Immunoreaction Enhancer Solution 1 (Toyobo) for 1 h at room temperature.
After washing with TBST (five times for 10 min each), the membranes were reacted with an appropriate dilution of horseradish-peroxidase-conjugated secondary antibody in Can Get Signal Immunoreaction Enhancer Solution 2 (Toyobo) for 30 min at room temperature. After washing with TBST (five times for 10 min each), the blots were visualized by an ECL Plus immunoblot detection system (GE Healthcare).
Construction of JFH1 mutant
We generated JFH1 (33) (DDBJ/EMBL/GenBank accession number AB047639) mutant constructs that contained alanine substitutions for hydrophobic residues in the NS4B region as follows : 4Bmtmt, W43A, V46A, W50A, F57A, I61A,   L64A, I242A, L246A, L249A, and I253A; 4Bmt0, W43A, V46A, W50A, F57A, I61A,   and L64A; 4Bmt1, W43A, V46A, and W50A; 4Bmt2, F57A, I61A, and L64A; FBS and seeded into dishes with a diameter of 10 cm (10 ml each). At 48 h post-transfection, LDs were prepared as described below.
Cell fractionation by step-wise sucrose density gradient OR6 cells were fractionated in sucrose density gradient as described previously (38) Finally, 0.97 ml of buffer A containing 2% sucrose was loaded on top. The step-wise gradient was centrifuged at 32,000 rpm, at 4°C for 90 min using an S52ST rotor (Hitachi Koki). Following centrifugation, the samples (0.5 ml each) were collected from the bottom.
Preparation of LDs
LDs were prepared as described previously (4) 2 , and 50 mM DTT at pH 7.4). The nuclei were removed by centrifugation at 2,000 rpm for 10 min at 4°C. The supernatant was collected and centrifuged at 16,000  g for 10 min at 4°C. The supernatant (S16, 1.25 ml) was mixed with 1.25 ml 1.04 M sucrose in isotonic buffer (50 mM HEPES, 100 mM KCl, 2 mM MgCl 2 , and Complete™ Protease Inhibitor Cocktail). The solution was set at the bottom of 5-ml 5PA ultracentrifuge tubes and 2.5 ml isotonic buffer was loaded onto the sucrose mixture. The gradient was centrifuged at 100,000  g in an S52ST rotor for 45 min at 4°C. After centrifugation, the LD fraction on the top of the gradient solution was collected as the first LD fraction (LD1). After 0.1 ml of the fraction was removed for analysis, the volume of the LD1 fraction was then adjusted to 1.25 ml with isotonic buffer and the fraction was mixed with 1.25 ml isotonic buffer containing 1.04 M sucrose. The fraction was set at the bottom of the ultracentrifuge tube and centrifuged again at 100,000  g, as described above. The LD fraction on the top of the gradient solution was collected as the second LD fraction (LD2). 
Titration of HCV infection
RESULTS
The intrinsic localization of NS4B to LDs
To clarify whether NS4B associated with LDs by itself, and, the mechanisms of LD targeting by NS4B, we performed fluorescent imaging using confocal microscopy ( Cherry-4B1-261-transfectant, about 4% and 15% of the cells were classified into category I and II, respectively (the results of the count are described in Table 1 ). Thus, NS4B colocalized with LDs in about 20% of cells.
We next expressed full-length NS4B fused with an epitope tag FLAG (amino acid sequence, DYKDDDDK) (pcDNA4B1-261-FLAG) and detected it using an anti-FLAG antibody (this is because we could not obtain antibodies that detected NS4B
in HCV-O via immunofluorescence). In most cases, the stain showed different sized dots, but no clear reticular pattern was obtained. However, we also found that, in some cells, the small dots of NS4B surrounded LDs, suggesting LD localization of FLAG-tagged NS4B (Fig. 1C) . Thus, NS4B localizes to LDs by itself. A similar pattern of LD localization was observed for HCV NS5A (tagged with myc [EQKLISEEDL] at the C terminus) and Core, which are known to associate with the LD surface (Fig. 1C) .
We also found that NS5A1-30, which lacks the N-terminal amphipathic -helix (amino acids 1-30), did not localize to LDs (data not shown). We conclude that NS4B
has an intrinsic activity to target the surface of LDs.
Subcellular distribution of NS4B in OR6 cells
We investigated whether intact NS4B targets LDs in the presence of other HCV proteins. We could not obtain antibodies applicable to immunofluorescent study for HCV-O; therefore, we adopted a biochemical approach. Subcellular fractionation of OR6 HCV-RNA-replicating cells was performed and distribution of HCV antigens was examined by immunoblotting. In OR6 cells, genome-length RNA of HCV-O (fused with
Renilla luciferase gene for monitoring of HCV genome replication) was stably replicated; hence, intact functional HCV antigens were expressed in the cells.
Distributions of cellular and HCV antigens in fractions obtained from OR6 cells by discontinuous sucrose density gradient (38) are shown in Fig. 2A (left). ADRP was detected most abundantly in the top fraction (fraction 10) followed by fraction 9,
suggesting that LDs were enriched in fraction 10 and partly in fraction 9. Calnexin, a marker protein of ER, was found mostly concentrated in fraction 2, showing that a major portion of ER was fractionated into fraction 2. A small portion of calnexin was also enriched in fraction 9 (and 10), suggesting that this fraction contained ER membranes associated with LDs. HCV antigens (Core, NS3, NS4B, NS5A, and NS5B)
were detected most abundantly in fraction 2, suggesting that these HCV antigens were associated with ER membranes. However, a small portion of HCV antigens, especially
Core, NS4B and NS5A, were clearly detected in fractions 10 and 9. This suggested that a substantial amount of HCV antigens, including NS4B, were present in LD-associated ER membranes or in the LD membrane itself in OR6 cells.
We also prepared LDs from OR6 cells using sucrose density gradient fractionation (by two rounds of discontinuous sucrose gradient ultracentrifugation) as previously described (4) (Fig. 2, right Fig. 2 ). NS3, NS4B, NS5A, and NS5B
proteins were all positive in both LD1 and LD2. NS4B was apparently enriched in LD1
as compared with the ratio of calnexin content between Sup (S16) and LD1, but was much less abundant in LD2 than in LD1. This distribution profile suggested that NS4B
was localized to LD-associated ER membranes rather than to the LD membranes themselves. Core protein was not detected in LD preparations as in those of OR6 cells, and instead it was precipitated to the bottom of the ultracentrifugation tube.
NS4B has two independent LD-targeting regions in the N-and C-terminal cytosolic domains
To determine which regions or motifs in NS4B were responsible for the targeting to LDs, various NS4B constructs of HCV-O were prepared as fusion proteins with mCherry (Fig. 3A) . The results were similar for mCherry and EGFP constructs; therefore, we chose mCherry as a tag protein together with Bodipy 493/503 to stain LDs.
We determined the activity of the N-and C-terminal cytosolic domains and the central membrane domain (Fig. 3B , Table 1 (Cherry-4B74-191) was expressed in cells, many ring-shaped localizations were seen, but they had no relation with LDs (Fig. 3B ). This ring-shape structure infers that NS4B activity can alter the membrane structure of ER, forming a "membranous web" (29) .
The C-terminal domain (Cherry-4B192-261) also showed LD localization, but to a lesser extent than that of the N-terminal region: ~10% of the cells were category I and 30% were category II. To identify the detailed LD-binding region, each terminal region was further divided into three, and their localization or that of the region spanning the two parts (two thirds of the terminal domain) was determined (Fig. 3C, D and Table 1 ). For the N-terminal region, Cherry-4B26-73 showed significant LD targeting. Within the amino acid residues 26-73, Cherry-4B26-49 showed no activity, whereas Cherry-4B50-73 was slightly active. Although the degree of localization was much lower than that of Cherry-4B1-73, the N-terminal site for LD localization was identified in the C-terminal half (or one third) of the N-terminal domain (Table 1) .
Regarding the C-terminal region, Cherry-4B218-261 and Cherry-4B240-261 were slightly active, suggesting that the C-terminal site is in the C-terminal half (or one third)
of the C-terminal domain, although the region had little activity by itself (Table 1) . Thus, NS4B had two independent regions for targeting LDs.
Hydrophobic amino acid residues in amphipathic -helices in NS4B are critical for
LD targeting
For both the N-and C-terminal sites an amphipathic -helix has been identified: amino acids 40-69 for the N-terminal region, and 229-253 for the C-terminal region; both of which were thought to mediate membrane association of NS4B (40, 41) . amphipathic helix) were present on the hydrophobic faces of the helices (Fig. 4) . To establish whether these residues were involved in LD targeting, we made various alanine substitutions for the residues. The influence of mutations was evaluated by reduction of LD localization as compared with the mother constructs (Fig. 4) .
When all of the six residues in the N-terminal amphipathic helix were substituted by alanine (Cherry-4B1-73mt1), the LD-targeting activity of Cherry-4B1-73 completely disappeared. As a result of a six-residue interval between 50W and 57F, the hydrophobic residues could be segregated into two clusters of three hydrophobic residues each. When the three residues of the cluster were substituted simultaneously, the influence on the LD-targeting activity was stronger by mutating the upstream cluster (Cherry-4B1-73mt2, containing W43A, L46A, and W50A) than the downstream cluster (Cherry-4B1-73mt3, containing F57A, I61A, and L64A) (Fig. 4) .
The single residue substitution in the upstream cluster, W43A, L46A, or W50A, did not significantly affect the LD-targeting activity of Cherry-4B1-73 (Cherry-4B1-73mt4, mt5 and mt6). The results indicated that the hydrophobic residues in the amphipathic helix were required for the LD-targeting activity in the N-terminal domain of NS4B, in which the residues in the upstream cluster (43W, 46L, and 50W) had a relatively stronger effect in a synergistic manner.
Regarding the C-terminal domain of NS4B, we made alanine substitutions for all the four residues simultaneously (Cherry-4B192-261mt1, containing I242A, L246A, L249A, and I253A), because the activity of the mother Cherry-4B192-261 was relatively low (Table 1) . This mutant showed no activity for LD targeting. Although the degree of contribution from each residue was not clear, these hydrophobic amino acids were considered to be critical for the LD-targeting activity of the C-terminal domain.
Similarly, we made six alanine substitutions simultaneously (W43A, L46A, W50A, F57A, I61A, and L64A) in a full-length NS4B construct (Cherry-4B1-261mt1) because of the relatively low targeting activity of the mother construct Cherry-4B1-261. This alanine mutant showed no apparent activity for LD targeting, indicating that the hydrophobic residues were critical for LD targeting of full-length NS4B.
When the expression of cherry fusion proteins was checked by immunoblotting, each construct showed its predicted molecular weight, although differences in by guest, on www.jlr.org Downloaded from expression level were seen among the different constructs ( Supplementary Fig. 3 ).
Cherry-4B1-73 and its mutants showed dual bands by unknown mechanisms; however, this seemed to be unrelated to the degree of LD-targeting for each protein. It should be noted that the 10 amino acid residues described here (43W, 46L, 50W, 57F, 61I, 64L, 242I, 246L, 249L, and 253I) were highly conserved among the wide variety of subtypes of HCV, supporting their critical role in the virus life cycle ( Supplementary Fig. 4 ).
JFH1 mutants harboring alanine substitutions abolishing LD-targeting activity of NS4B are defective for replication
To clarify the importance of LD targeting of NS4B for replication of HCV, we examined JFH1 mutants that contained alanine substitutions of hydrophobic residues critical for LD targeting in the NS4B region. The 10 hydrophobic residues, 43W, 46V (L in strain O), 50W, 57F, 61I, 64L, 242I, 246L, 249L, and 253I, were divided into three clusters as described above and mutants were created for each cluster of three or four simultaneous alanine substitutions: 4Bmt1, W43A, V46A, and W50A; 4Bmt2, F57A, I61A, and L64A; and 4Bmt3, I242A, L246A, L249A, and I253A. When the wild-type and mutant RNAs were transfected into Oc cells, wild-type JFH1 released an increasing number of infectious virions (Fig. 5A ), whereas the cluster mutants (4Bmt1, 4Bmt2, and 4Bmt3) produced no detectable infectious virions. For all these mutants, no HCV antigens were detected by immunoblotting in transfected cells (Core, NS4B, and NS5A was tested; data not shown). The cluster mutants were defective for virus replication.
We then concentrated on the first N-terminal cluster and created single alanine substitution mutants for the three hydrophobic residues, W43A, V46A and W50A, because the cluster was considered to be most effective for LD targeting of NS4B as described above. When RNAs were transfected into Oc cells, the mutants released different numbers of infectious virions (Fig. 5A ). As compared with wild-type, W43A
released only 1/300 to 1/1000 of infectious virions, whereas V46A released comparable amounts of virions. W50A released no detectable infectious virions. Interestingly, W43A mutant, as well as V46A, expressed comparable amounts of HCV antigens as wild-type as confirmed by immunoblotting (Fig. 5A) . In contrast, expression of HCV antigens was negligible for W50A (only faint bands were seen with longer exposure;
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data not shown). Although W50A mutant was of interest to clarify the mechanisms of the defect, further analysis was not performed.
We then analyzed by confocal microscopy LD targeting of NS4B for W43A mutant, comparing it with that of the wild-type (Fig. 5B and Supplementary Fig. 5 ). We could not obtain antibodies for immunofluorescent detection of JFH1 NS4B, therefore, we used anti-NS4AB polyclonal antibody, which reacted with both NS4A and NS4B
proteins. Distributions of NS4B (and/or 4A) and other antigens were observed by confocal microscopy for transfectants of wild-type and W43A ( Fig. 5B and Supplementary Fig. 5 ). 5 ) and W43A, we observed clear or broken ring-shape staining surrounding the LDs and also the stain concentrated around LDs. We also tried imaging with anti-NS3 and anti-NS5B antibodies, which were used for immunoblotting of JFH1 antigens, however, the results of staining were not informative. The percentages of transfectants positive for LD association of antigens were compared for wild-type and W43A (Fig. 5B,   bottom ). In W43A, LD association of NS4B (and/or 4A) was markedly decreased as compared with wild-type, while that of Core and NS5A was mildly decreased. For V46A mutant, percentages of positive transfectants were 97, 28, and 79%, for Core, NS4AB, and NS5A, respectively.
Finally, we purified LD fractions from W43A transfectant and analyzed for HCV antigens by immunoblotting ( Fig. 5C and Supplementary Fig. 6 ). In contrast to LD fractions from wild-type ( Supplementary Fig. 2 ), calnexin contents in LD1 and LD2
were comparable, suggesting that W43A mutation in NS4B affects membrane micro-architecture around LDs. This suggestion was supported by drastic changes in distribution of NS4B (and/or 4A) around LDs, where it seemed as if the distribution pattern of the ER membranes themselves was altered by the mutation of NS4B (Fig. 5B) .
In both LD1 and LD2, NS4B was not detected by immunoblotting, suggesting that NS4B harboring W43A mutation could not interact with LDs (Fig. 5C) . The other HCV antigens, NS3, NS5A, and NS5B, were detected in both LD1 and LD2 ( Supplementary   Fig. 6 ). Also in W43A, the Core protein was not detected in LD fractions but in the ultracentrifugation pellet.
DISCUSSION
In the present study, we demonstrated that HCV NS4B has the ability to target
LDs. In the imaging analysis using Cherry constructs, some expressed NS4B showed ring-shape structures at the margins of LDs, suggesting that NS4B was present near to functional HCV proteins were present. We found that NS4B existed in the crude LD fraction (LD1 in Fig. 2 right) , suggesting that NS4B was localized to the membranes associated with LDs. Analysis of LD fractions from JFH1-RNA-transfected cells also suggested that NS4B localized to such LD-associated ER membranes rather than on the LD surface membranes themselves ( Supplementary Fig. 2 ).
In cellular LD-targeting proteins, the targeting mechanism is thought to be complexed and multifactorial (1). However, two major required features of amino acid sequence have been proposed: one is the amphipathic -helix (19) (20) (21) (22) (23) , and the other is a rather undefined hydrophobic region (24) (25) (26) . biogenesis is believed to be initiated from the accumulation of lipids between the two membrane leaflets of the ER (1-3) ; therefore, another explanation is that proteins initially target the ER membranes and are then assorted on the emerging LD membranes by lateral diffusion with the aid of additional, yet undefined mechanisms. The latter targeting model has also been proposed for the HCV Core, in which the truncated form of the Core protein targets LDs more efficiently (22) . However, this LD-assorting mechanism is unlikely for NS4B because NS4B has at least four transmembrane helices by which the protein is integrated into the ER bilayer membrane (43) . It should be noted that LDs are surrounded by lipid monolayers. Taking together the proposed sorting mechanisms of other LD-targeting proteins with the result that LD-targeting sites were present in each cytosolic domain, a likely model is that NS4B is present in the ER but, simultaneously, both cytosolic terminal domains interact with the LD surface membrane through the hydrophobic residues in amphipathic helices; NS4B tethers or catches the emerging LDs on or very near to the ER (Fig. 6) . The results from biochemical analysis of LD preparations, in which NS4B seemed to be present in LD-associated membranes rather than on the LD surface membranes themselves, support this model. To clarify whether NS4B and ADRP were present in the identical membrane structure or not, we also performed FRAP (fluorescence recovery after photobleaching) analysis at the site of colocalization of Cherry-4B1-261 and EGFP-ADRP. Unfortunately, definitive data have not been obtained, because of the time resolution constraints of our equipment. We think that further investigation is needed to prove our hypothesis.
Our imaging study also revealed that hydrophobic residues in amphipathic In contrast to the JFH1 system, the impact of W43A mutation was unclear from the overexpression results using a truncated form of NS4B (Fig. 4) . According to our model ( Fig. 6 ), NS4B mediates association of LDs with ER membranes. When LDs move away from the site of association, a large force may act to disrupt the interaction between NS4B and LD membranes, and the residue 43W may be important to maintain the interaction as it is highly hydrophobic. The interactions of each of the hydrophobic residues involved in LD targeting depends on the adopted conformations of NS4B, and those of molecules interacting with NS4B (HCV proteins, cellular proteins, or lipids); the changes in the mutual positioning of these molecules can induce steric hindrance.
The 43W residue might be critical in such microenvironments. In contrast, the truncated form of NS4B (amino acids 1-73) may target LDs directly in a less-regulated manner.
This interaction may not be related to ER membranes and hence is not affected by LD movements. The 43W residue influence is less than that of the intact NS4B.
We used an anti-NS4AB antibody, therefore, it remains to be resolved which antigens were observed in our imaging study ( Fig. 5B and Supplementary Fig. 5 ). NS4A
by guest, on www.jlr.org Downloaded from is a small protein consisting of 54 amino acids and is closely associated with NS3 to form NS3-4A complex. NS3-4A complex is thought to associate with ER membranes through the N-terminal hydrophobic -helix of NS4A as a membrane anchor (46) . Thus, it is unlikely that the W43A mutation of NS4B directly elicits solely the loss of association between NS3-4A and LDs as seen in Fig. 5B . At present, it is also not known whether NS3-4A complex has an activity by itself to target LDs, although NS3
harbors an amphipathic helix  0 that mediates membrane association (46) . The most straightforward interpretation is that both NS4B and NS4A (and NS3) are present on ER membranes close to LDs, via the function of NS4B, and that W43A mutation causes loss of association with (or proximity to) LDs of both these proteins (but mostly NS4B). 
